These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 28594391)

  • 1. Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients.
    Schulz H; Schmoeckel E; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9.
    Schulz H; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U; Schmoeckel E
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.
    Grosset AA; Labrie M; Vladoiu MC; Yousef EM; Gaboury L; St-Pierre Y
    Oncotarget; 2016 Apr; 7(14):18183-203. PubMed ID: 26933916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of galectin-7 in epithelial ovarian cancer.
    Kim HJ; Jeon HK; Lee JK; Sung CO; Do IG; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
    Anticancer Res; 2013 Apr; 33(4):1555-61. PubMed ID: 23564797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectins-1, -3, -7, -8 and -9 as prognostic markers for survival in epithelial ovarian cancer: A systematic review and meta-analysis.
    Pergialiotis V; Papoutsi E; Androutsou A; Tzortzis AS; Frountzas M; Papapanagiotou A; Kontzoglou K
    Int J Gynaecol Obstet; 2021 Mar; 152(3):299-307. PubMed ID: 33156523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary carcinoma cells and affects both cancer cell proliferation and adhesion to laminin-1 and fibronectin.
    van den Brûle F; Califice S; Garnier F; Fernandez PL; Berchuck A; Castronovo V
    Lab Invest; 2003 Mar; 83(3):377-86. PubMed ID: 12649338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Galectins in Tumors and in Clinical Immunotherapy.
    Chou FC; Chen HY; Kuo CC; Sytwu HK
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion.
    Kim HJ; Jeon HK; Cho YJ; Park YA; Choi JJ; Do IG; Song SY; Lee YY; Choi CH; Kim TJ; Bae DS; Lee JW; Kim BG
    Eur J Cancer; 2012 Aug; 48(12):1914-21. PubMed ID: 22386573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of galectin-1 expression in non-small cell lung cancer patients.
    Carlini MJ; Roitman P; Nuñez M; Pallotta MG; Boggio G; Smith D; Salatino M; Joffé ED; Rabinovich GA; Puricelli LI
    Lung Cancer; 2014 Apr; 84(1):73-8. PubMed ID: 24560493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin expression profiling identifies galectin-1 and Galectin-9Δ5 as prognostic factors in stage I/II non-small cell lung cancer.
    Schulkens IA; Heusschen R; van den Boogaart V; van Suylen RJ; Dingemans AM; Griffioen AW; Thijssen VL
    PLoS One; 2014; 9(9):e107988. PubMed ID: 25259711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications.
    Mohamed RM; Emam A; Abdelfattah MM; Abdel-Mageed AI; Abdelhafeez MA; Helwa R
    World J Surg Oncol; 2022 Sep; 20(1):276. PubMed ID: 36050693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Galectin-3 and its clinical significance in ovarian carcinoma.
    Kim MK; Sung CO; Do IG; Jeon HK; Song TJ; Park HS; Lee YY; Kim BG; Lee JW; Bae DS
    Int J Clin Oncol; 2011 Aug; 16(4):352-8. PubMed ID: 21327452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkers.
    Labrie M; De Araujo LOF; Communal L; Mes-Masson AM; St-Pierre Y
    Sci Rep; 2017 Oct; 7(1):13244. PubMed ID: 29038585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermodynamic binding studies of galectin-1, -3 and -7.
    Brewer CF
    Glycoconj J; 2002; 19(7-9):459-65. PubMed ID: 14758069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-1 and galectin-3: plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population.
    Aggarwal S; Sharma SC; Das SN
    Clin Chim Acta; 2015 Mar; 442():13-21. PubMed ID: 25578395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Intracellular Galectin-8 and -9 in Endometrial Cancer.
    Beyer S; Wehrmann M; Meister S; Trillsch F; Ganster F; Schmoeckel E; Corradini S; Mahner S; Jeschke U; Kessler M; Burges A; Kolben T
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varied expression and localization of multiple galectins in different cancer cell lines.
    Satelli A; Rao PS; Gupta PK; Lockman PR; Srivenugopal KS; Rao US
    Oncol Rep; 2008 Mar; 19(3):587-94. PubMed ID: 18288388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-8 and -9 as prognostic factors for cervical cancer.
    Beyer S; Wehrmann M; Meister S; Kolben TM; Trillsch F; Burges A; Czogalla B; Schmoeckel E; Mahner S; Jeschke U; Kolben T
    Arch Gynecol Obstet; 2022 Oct; 306(4):1211-1220. PubMed ID: 35377045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Galectin-7 and Low Galectin-8 Expression and the Combination of both are Negative Prognosticators for Breast Cancer Patients.
    Trebo A; Ditsch N; Kuhn C; Heidegger HH; Zeder-Goess C; Kolben T; Czogalla B; Schmoeckel E; Mahner S; Jeschke U; Hester A
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32290551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-8 predicts postoperative recurrence of patients with localized T1 clear cell renal cell carcinoma.
    Liu Y; Xu L; Zhu Y; Zhang W; Liu W; Liu H; Xu J
    Urol Oncol; 2015 Mar; 33(3):112.e1-8. PubMed ID: 25499921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.